文献速递白血病造血干细胞移植与细胞治疗

运动动员的淋巴细胞增强细胞因子诱导记忆样NK细胞抗髓系白血病功能

Exercise-mobilized lymphocytes enhance the function of cytokine-induced memory-like NK cells against myeloid leukemia.
PubMed 文献 · Blood Adv · 2026-01-01

该研究在18名健康供者中测试运动动员的NK细胞能否增强IL-12/15/18激活的NK细胞体外及CIML NK细胞体内抗白血病功能。运动动员后经IL-12/15/18激活的aNK-X细胞对2株髓系白血病细胞系杀伤更强,干扰素γ产生、脱颗粒及活化表型增加;小鼠中CIML NK-X联合DLI-X延长植入、延缓肿瘤进展并延长生存。

要点

  • 运动动员NK细胞经IL-12/15/18激活后体外抗髓系白血病细胞毒作用优于静息来源aNK。
  • aNK-X细胞干扰素γ产生、脱颗粒及NKG2A-/NKG2D+、CD57+、CD16+表型增强。
  • 小鼠中CIML NK-X联合DLI-X较标准方案延长植入、延缓肿瘤进展并延长生存。

核心结论

  • 运动诱导的NK细胞动员联合细胞因子预激活可产生抗白血病活性更优的过继细胞治疗产品。

研究设计与样本

  • 18名健康供者进行20分钟递增骑行至80%最大摄氧量,静息和运动时采血。
  • NK细胞经IL-15或IL-12/15/18过夜培养,检测体外细胞毒性和白血病荷瘤异种小鼠肿瘤控制。

主要发现

  • 同一供者aNK-X细胞对2株髓系白血病细胞系细胞毒性强于aNK细胞,伴干扰素γ产生增加、脱颗粒增强及NKG2A-/NKG2D+、CD57+、CD16+表型富集。
  • NK-X细胞细胞毒性强于NK细胞,与aNK细胞相当,但aNK-X细胞优于两者。
  • 小鼠中CIML NK-X联合DLI-X较CIML NK联合标准DLI延长植入、延缓肿瘤进展并延长生存。

临床怎么用

  • 运动动员供者NK细胞联合IL-12/15/18预激活可能作为增强CIML NK过继治疗抗髓系白血病活性的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Short-term activation of natural killer (NK) cells with interleukin-12 (IL-12), IL-15, and IL-18 (IL-12/15/18) gives rise to cytokine-induced memory-like (CIML) NK cells after adoptive transfer, which exhibit enhanced antitumor activity, proliferation, and persistence. Clinical trials in high-risk leukemia have shown encouraging results, yet significant challenges remain, particularly the limited durability of cytotoxicity and the failure to achieve sustained remission. We recently demonstrated that acute exercise induces a threefold to fourfold increase in circulating NK cells enriched for gene programs and surface proteins linked to antitumor activity. Here, we tested whether exercise-mobilized NK cells could improve the function of IL-12/15/18-activated NK (aNK) cells in vitro and CIML NK cells in vivo. Eighteen healthy donors performed 20 minutes of graded cycling up to 80% maximal oxygen uptake, with blood collected at rest and during exercise. NK cells purified from rest and exercise (NK-X) were cultured overnight with IL-15 (NK or NK-X) or IL-12/15/18 (aNK or aNK-X). End points included in vitro cytotoxicity and tumor control in leukemia-bearing xenogeneic mice. aNK-X cells exhibited stronger cytotoxicity against 2 myeloid leukemia cell lines than aNK cells from the same donors, accompanied by increased interferon gamma production, enhanced degranulation, and an enriched phenotype (higher NKG2A-/NKG2D+, CD57+, CD16+). Notably, NK-Xs displayed greater cytotoxic activity than NKs and were comparable with aNK cells, although aNK-X cells outperformed both. In mice, CIML NK-X cells combined with exercise-mobilized donor lymphocyte infusion (DLI-X) prolonged engraftment, delayed tumor progression, and extended survival relative to CIML NK cells combined with standard DLI. These findings demonstrate that exercise-induced NK cell mobilization combined with cytokine preactivation yields an adoptive cell therapy product with superior antileukemic activity. This trial was registered at www.ClinicalTrials.gov as NCT06643221.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Batatinha H, Valenzuela AM, Filioglou D, et al. Exercise-mobilized lymphocytes enhance the function of cytokine-induced memory-like NK cells against myeloid leukemia. Blood Adv. 2026. PMID: 41538301. doi:10.1182/bloodadvances.2025018345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。